An endovascular aneurysm repair has become an important therapeutic option for the management of patients with aortic aneurysms. Early advantages of the endovascular technique have been well documented. Patients with aortic aneurysms undergoing these procedures are usually elderly, which increases the likelihood of comorbidities. With the increased use of vascular devices, potential complications such as graft limb occlusion need to be widely understood, so they can be recognized and treated early. We recently treated an 85-year-old man with acute endovascular graft limb occlusion after an elective anterior resection for rectal cancer, and we discuss some factors that may have contributed to this complication.
PurposeInguinal hernia repair is one of the most frequently performed operations in general surgical practice. A variety of techniques have been used in the past with different results. The aim of the present study is to report our experience of inguinal hernia repair using the Kugel patch and to measure the frequency of postoperative recurrence and chronic groin pain.
MethodologyData were recorded prospectively from a series of 333 inguinal hernia repairs performed between January 2004 to December 2006 using the Kugel patch technique. Wound infection, seroma, haematoma urinary retention, 6-month recurrence and chronic groin pain were the outcome measures.
ResultsThe Kugel patch hernia repairs were performed in 284 patients during the 3-year period. There were no recurrences or chronic groin pain within 6 months of the 333 repairs. There was only one reported wound infection. The average operating time for bilateral hernia repair was 40.5 minutes (SD 8.8). Recurrent hernias took an average of 26 minutes (SD6.2) to repair whilst unilateral hernias took an average of 23 minutes (SD 6.8). 5 (1.8%) of the 284 patients had urinary retention. The average operating time for 136 direct procedures was 27 minutes compared with 25 minutes for the 148 indirect procedures (p = 0.096, t-test).
ConclusionIn this prospective series the Kugel hernia repair is associated with no post hernia repair groin pain and no recurrence within 6 months of the procedure. It is inexpensive compared with laparoscopic repair, and allows the surgeon to cover all potential defects with one piece of mesh.
PurposeTo review the experience with laparoscopic splenectomy, to determine it's efficacy for treating immune thrombocytopaenic purpura (ITP) and to highlight key technical issues with the operation.
MethodologyAll splenectomies performed between 1992 and 2005 were identified from the Otago Surgical Audit and the clinical notes reviewed, including the laboratory records for follow-up data related to the haematologic cases.
ResultsThere were 289 splenectomies performed over the 13 year period. The indications were trauma (111, 38%), haematologic disease (93, 32%), incidental (40, 14%) splenic malignancy (39, 13%), and other (8, 3%). Of the 68 patients with ITP, 49 (72%) had a lateral laparoscopic splenectomy (LLS) with no conversions, a 5% complication rate and one mortality. Based on platelet counts and the requirement for maintenance steroids there was a complete response in 44 (68%) patients at >6 months, a partial response in 16 (24%) and no response in 5 (8%) patients. A short video presentation will highlight the key steps for the safe and efficient performance of the LLS, including patient and port positioning, the use of ultrasonic dissection, splenic pedicle stapling, and morcellation. The indications for hand-port assisted laparoscopic and open splenectomy will be discussed.
ConclusionsThe LLS is the preferred approach to splenectomy for all but massive splenomegaly and can be performed safely with careful attention to key technical issue...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.